Psychedelic Safety & Research

Clinical trials, drug testing, pregnancy safety, contraindications, and scientific research.

A Psychedelic That Mimics Meditation? New Research Says Yes

A powerful psychedelic may produce the same brain state as decades of meditation practice.

Read More

American Society of Anesthesiologists Calls For Stronger Ketamine Oversight As Use Surges

One of the country’s most influential anesthesia groups is warning that ketamine telehealth's safety standards have not kept pace.

Read More

Introducing HealingChat: HealingMaps’ Ai Chatbot Connects Users to Psychedelic-Assisted Therapy Information

We created an AI-powered chatbot to help our psychedelic-curious visitors find the answers they're looking for.

Read More

Study Shows the Connection Between Psychedelic Experiences and Heart Activity

Scientists have uncovered a fascinating connection between psychedelic experiences and heart activity, shedding new light on how the body responds

Read More

Psychedelics Show Promise for Smoking Cessation Research

Classic psychedelics like psilocybin and LSD may help people quit cigarettes, but researchers caution that evidence remains preliminary.

Read More

FDA Grants Priority Vouchers to Three Psychedelic Drug Programs

The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.

Read More

The Highest Reviewed Psychedelic Integration Therapists in Kansas City

Discover the top psychedelic integration therapists in Kansas City, who are transforming lives with their unique approaches. From Dr. Samantha

Read More

The Power of Group Dynamics in Psychedelic Therapy

A growing body of research suggests that psychedelics can do more than just alter perception—they can deepen human connections.

Read More

A Breakthrough for Depression Treatment: FDA Fast Tracks atai’s Novel Nasal Spray

The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression

Read More

FDA Faces a Core Problem in Psychedelic Trials: Everyone Knows Who Got the Drug

In many studies, participants can tell when they received the active drug. That makes these trials functionally open label.

Read More

Explore Psychedelic Therapy Regions